Search

everythinglearnresearchcommunity

for

Search:↓

COVID-19 can cause hair and nail disorders after infection.

A 17-year-old girl had severe, on-and-off hair loss, likely due to COVID-19. She was treated with Vitamin D3, biotin, and other supplements, and saw some improvement within a month.

Nursing staff's mental health was affected during the COVID-19 pandemic.

More research is needed to understand sex and racial differences in long COVID.

Age affects how certain proteins involved in COVID-19 infection are expressed in mice, but sex hormones and heart injury do not.

The DNA convention was a valuable opportunity for learning and networking, especially after COVID-19.

5-alpha reductase inhibitors, like finasteride and dutasteride, are used for prostate issues, hair loss, and excessive hair growth, may help with COVID-19, but can cause sexual and mental health side effects, and their use in preventing prostate cancer needs more examination.

Children's screen time increased during the pandemic, causing various health issues.

Pharmacists play a key role in managing the use of anxiety medications and ensuring patients use them correctly.

The conclusion is that individual differences in COVID-19 severity are influenced by factors like age, sex, race, and genetics, which are important for personalized medicine.

Existing drug dexamethasone may lower death risk in severe COVID-19 cases; more research needed for other drugs.

COVID-19 and hypopituitarism (reduced pituitary gland function) are linked, with the latter's related health issues potentially worsening COVID-19 outcomes, and COVID-19 possibly increasing risk for pituitary complications.

COVID-19 may affect male fertility and women might have better outcomes due to hormonal and immune differences.

Androgens may worsen COVID-19 and hair loss could indicate the disease's severity.

Men generally have more severe COVID-19 cases and higher death rates than women due to biological differences.

Male cancer patients have a higher risk of severe illness and death from COVID-19 than female patients.

Repurposing existing drugs for COVID-19 shows promise but requires more research to confirm effectiveness.

A woman lost over 80% of her hair due to a condition called telogen effluvium after having COVID-19.

A man's hair grew back to almost normal 7 months after COVID-19 without needing treatment.

Long COVID patients have more health issues than non-infected people.

Over half of the participants in a Saudi Arabian survey experienced hair loss after COVID-19, affecting women and younger people more, with a small percentage feeling a severe impact on their lives.

The COVID-19 pandemic led to fewer patient visits, more visits by older adults, an increase in cutaneous T-cell lymphoma cases, and a rise in noncosmetic procedures at a dermatology clinic.

Men, especially older ones with health issues like prostate cancer, may have worse COVID-19 outcomes and could benefit from therapies targeting male hormones.

COVID-19 can cause skin problems in children.

COVID-19 diagnosis is linked to new or worsening hair diseases, with stress from the pandemic likely contributing.

COVID-19 can cause hair loss, and managing it involves counseling, diet changes, and treatments.

Testosterone may influence COVID-19 severity and outcomes.

Testosterone's effects on COVID-19 are unclear and need more research.

Sex hormones like estrogen and testosterone may affect COVID-19 severity differently in men and women, potentially influencing prevention and treatment strategies.

Sex hormones may affect COVID-19 severity, with estrogen possibly reducing risk and testosterone potentially increasing it.